Cargando…
Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics
Chimeric antigen receptor (CAR) therapy is based on patient blood-derived T cells and natural killer cells, which are engineered in vitro to recognize a target antigen in cancer cells. Most CAR-T recognize target antigens through immunoglobulin antigen-binding regions. Hence, CAR-T cells do not requ...
Autores principales: | Guerra, Emanuela, Di Pietro, Roberta, Basile, Mariangela, Trerotola, Marco, Alberti, Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745734/ https://www.ncbi.nlm.nih.gov/pubmed/35008832 http://dx.doi.org/10.3390/ijms23010405 |
Ejemplares similares
-
Distinct lung cancer subtypes associate to distinct drivers of tumor progression
por: Relli, Valeria, et al.
Publicado: (2018) -
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody
por: Guerra, Emanuela, et al.
Publicado: (2023) -
A non-mutated TROP2 fingerprint in cancer genetics
por: Guerra, Emanuela, et al.
Publicado: (2023) -
A deterministic code for transcription factor-DNA recognition through computation of binding interfaces
por: Trerotola, Marco, et al.
Publicado: (2022) -
Epigenetic inheritance and the missing heritability
por: Trerotola, Marco, et al.
Publicado: (2015)